BioNote, Inc. (KRX: 377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,770.00
-5.00 (-0.10%)
Dec 20, 2024, 9:00 AM KST
15.50%
Market Cap 486.81B
Revenue (ttm) 99.81B
Net Income (ttm) 40.35B
Shares Out 102.06M
EPS (ttm) 394.18
PE Ratio 12.10
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 97,262
Open 4,760.00
Previous Close 4,775.00
Day's Range 4,690.00 - 4,800.00
52-Week Range 3,865.00 - 6,400.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.